Pharma trends in the AI era

According to the latest global research, 95% of pharmaceutical companies are investing in artificial intelligence (AI) capabilities, while AI technology is reducing the time needed to develop new drugs from five to six years to just one year. For pharmaceutical companies, AI is transforming and improving the way drugs are developed, manufactured, and distributed. Miloš Nikolić, director of the information technology sector at the Galenika company, wrote about some of the key advantages in an article for Nedeljnik. 

You can read the article here.